Zobrazeno 1 - 6
of 6
pro vyhledávání: '"van Dinter JT"'
Autor:
Martin MV; CureVac Netherlands B.V., Amsterdam, the Netherlands., Aguilar-Rosas S; CureVac Netherlands B.V., Amsterdam, the Netherlands., Franke K; CureVac Netherlands B.V., Amsterdam, the Netherlands., Pieterse M; CureVac Netherlands B.V., Amsterdam, the Netherlands., Langelaar JV; CureVac Netherlands B.V., Amsterdam, the Netherlands., Schreurs R; CureVac Netherlands B.V., Amsterdam, the Netherlands., Bijlsma MF; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands., Besselink MG; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands., Koster J; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, the Netherlands., Timens W; Department of Pathology and Medical Biology, University of Groningen, University, Medical Center Groningen, the Netherlands., Khasraw M; Duke University Medical Center, Duke University, Durham, North Carolina., Ashley DM; Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University, Durham, North Carolina., Keir ST; Duke University Medical Center, Duke University, Durham, North Carolina., Ottensmeier CH; Liverpool Head and Neck Centre, Institute of Systems, Molecular and Integrative Biology, University of Liverpool and Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, UK., King EV; Department of Otorhinolaryngology, Head and Neck Surgery, Poole Hospital, Poole, UK., Verheij J; Amsterdam UMC, location University of Amsterdam, Department of Pathology, Amsterdam, the Netherlands., Waasdorp C; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam, the Netherlands., Valk PJM; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Engels SAG; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Oostenbach E; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Dinter JT; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Hofman DA; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Mok JY; Sanquin Reagents, Sanquin, Amsterdam, the Netherlands., van Esch WJE; Sanquin Reagents, Sanquin, Amsterdam, the Netherlands., Wilmink H; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Amsterdam UMC, location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands., Monkhorst K; Netherlands Cancer Institute, Amsterdam, the Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Poel D; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the, Netherlands., Hiltermann TJN; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, the Netherlands., Kempen LCLTV; Department of Pathology and Medical Biology, University of Groningen, University, Medical Center Groningen, the Netherlands.; University of Antwerp, Antwerp University Hospital, Edegem, Belgium., Groen HJM; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, the Netherlands., Aerts JGJV; Erasmus Medical Center, Pulmonary Medicine, Rotterdam, the Netherlands., Heesch SV; The Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Löwenberg B; CureVac Netherlands B.V., Amsterdam, the Netherlands., Plasterk R; CureVac Netherlands B.V., Amsterdam, the Netherlands., Kloosterman WP; CureVac Netherlands B.V., Amsterdam, the Netherlands.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Jun 04; Vol. 12 (6), pp. 759-778.
Autor:
Cornel AM; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van der Sman L; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van Dinter JT; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Arrabito M; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Center of Pediatric Hematology & Oncology, University of Catania, Catania, Italy., Dunnebach E; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van Hoesel M; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Kluiver TA; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Lopes AP; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Dautzenberg NMM; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Dekker L; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van Rijn JM; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., van den Beemt DAMH; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Buhl JL; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., du Chatinier A; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Barneh F; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Lu Y; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Lo Nigro L; Center of Pediatric Hematology & Oncology, University of Catania, Catania, Italy., Krippner-Heidenreich A; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Sebestyén Z; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands., Kuball J; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.; Department of Hematology, UMC Utrecht, Utrecht, The Netherlands., Hulleman E; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Drost J; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Heesch S; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Heidenreich OT; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Peng WC; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Nierkens S; Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands S.Nierkens-2@prinsesmaximacentrum.nl.; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Mar 21; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 21.
Autor:
Hofman DA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Ruiz-Orera J; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany., Yannuzzi I; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Murugesan R; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Brown A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Clauser KR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Condurat AL; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., van Dinter JT; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Engels SAG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Goodale A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands., Abid T; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Wang L; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Zhou KN; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Vogelzang J; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA., Ligon KL; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215, USA; Department of Pathology, Boston Children's Hospital, Boston MA 02115, USA., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45229, USA., Roth JA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Hubner N; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany; Charité-Universitätsmedizin, 10117 Berlin, Germany; German Centre for Cardiovascular Research, Partner Site Berlin, 13347 Berlin, Germany., Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., Bandopadhayay P; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA., van Heesch S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the Netherlands. Electronic address: s.vanheesch@prinsesmaximacentrum.nl., Prensner JR; Department of Pediatrics, Division of Pediatric Hematology/Oncology and Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: prensner@umich.edu.
Publikováno v:
Molecular cell [Mol Cell] 2024 Jan 18; Vol. 84 (2), pp. 261-276.e18. Date of Electronic Publication: 2024 Jan 03.
Autor:
Hofman DA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands.; These authors contributed equally., Ruiz-Orera J; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.; These authors contributed equally., Yannuzzi I; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Murugesan R; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Brown A; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Current address: Arbor Biotechnologies, Cambridge, MA, 02140, USA., Clauser KR; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Condurat AL; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., van Dinter JT; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands., Engels SAG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands., Goodale A; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands., Abid T; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Wang L; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Zhou KN; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Current address: Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, 91101, USA., Vogelzang J; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02215, USA., Ligon KL; Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, 02215, USA.; Department of Pathology, Boston Children's Hospital, Boston MA 02115., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, 45229, USA., Roth JA; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Hubner N; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.; Charité-Universitätsmedizin, 10117 Berlin, Germany.; German Centre for Cardiovascular Research, Partner Site Berlin, 13347 Berlin, Germany., Golub TR; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA., Bandopadhayay P; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA., van Heesch S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, the Netherlands., Prensner JR; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02115, USA.; Current address: Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 May 06. Date of Electronic Publication: 2023 May 06.
Autor:
Palomar-Siles M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Heldin A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Zhang M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Strandgren C; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Yurevych V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Dinter JT; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Engels SAG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hofman DA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Öhlin S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Meineke B; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Bykov VJN; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., van Heesch S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wiman KG; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Klas.Wiman@ki.se.
Publikováno v:
Cell death & disease [Cell Death Dis] 2022 Nov 25; Vol. 13 (11), pp. 997. Date of Electronic Publication: 2022 Nov 25.
Autor:
Pei J; Department of Nephrology and Hypertension, DIGD, UMC Utrecht, University of Utrecht, Utrecht, Netherlands.; Department of Cardiology, Division Heart & Lungs, UMC Utrecht, University of Utrecht, Utrecht, Netherlands.; Regenerative Medicine Utrecht (RMU), UMC Utrecht, University of Utrecht, Utrecht, Netherlands., Harakalova M; Department of Cardiology, Division Heart & Lungs, UMC Utrecht, University of Utrecht, Utrecht, Netherlands.; Regenerative Medicine Utrecht (RMU), UMC Utrecht, University of Utrecht, Utrecht, Netherlands.; Department of Pathology, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., Treibel TA; Institute of Cardiovascular Science, University College London, London, UK., Lumbers RT; Institute of Cardiovascular Science, University College London, London, UK., Boukens BJ; Department of Medical Biology, AMC, Amsterdam, Netherlands., Efimov IR; Department of Biomedical Engineering, GWU, Washington, D.C, USA., van Dinter JT; Department of Cardiology, Division Heart & Lungs, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., González A; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Carlos III Institute of Health, Madrid, Spain., López B; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Carlos III Institute of Health, Madrid, Spain., El Azzouzi H; Department of Cardiology, Division Heart & Lungs, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., van den Dungen N; Laboratory of Clinical Chemistry and Hematology, UMC Utrecht, Utrecht, Netherlands., van Dijk CGM; Department of Nephrology and Hypertension, DIGD, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., Krebber MM; Department of Nephrology and Hypertension, DIGD, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., den Ruijter HM; Department of Experimental Cardiology, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., Pasterkamp G; Laboratory of Clinical Chemistry and Hematology, UMC Utrecht, Utrecht, Netherlands., Duncker DJ; Division of Experimental Cardiology, Department of Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands., Nieuwenhuis EES; Division of Paediatrics, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., de Weger R; Department of Pathology, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., Huibers MM; Department of Pathology, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., Vink A; Department of Pathology, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., Moore JH; Institute for Biomedical Informatics, UPENN, Philadelphia, USA., Moon JC; Institute of Cardiovascular Science, University College London, London, UK., Verhaar MC; Department of Nephrology and Hypertension, DIGD, UMC Utrecht, University of Utrecht, Utrecht, Netherlands., Kararigas G; Charité - Universitätsmedizin Berlin, and DZHK (German Centre for Cardiovascular Research), partner site, Berlin, Germany., Mokry M; Regenerative Medicine Utrecht (RMU), UMC Utrecht, University of Utrecht, Utrecht, Netherlands. M.Mokry@umcutrecht.nl.; Laboratory of Clinical Chemistry and Hematology, UMC Utrecht, Utrecht, Netherlands. M.Mokry@umcutrecht.nl.; Division of Paediatrics, UMC Utrecht, University of Utrecht, Utrecht, Netherlands. M.Mokry@umcutrecht.nl., Asselbergs FW; Department of Cardiology, Division Heart & Lungs, UMC Utrecht, University of Utrecht, Utrecht, Netherlands. F.W.Asselbergs@umcutrecht.nl.; Institute of Cardiovascular Science, Faculty of Population Health Science, University College London, London, UK. F.W.Asselbergs@umcutrecht.nl.; Health Data Research UK and Institute of Health Informatics, University College London, London, UK. F.W.Asselbergs@umcutrecht.nl., Cheng C; Department of Nephrology and Hypertension, DIGD, UMC Utrecht, University of Utrecht, Utrecht, Netherlands. K.L.Cheng-2@umcutrecht.nl.; Regenerative Medicine Utrecht (RMU), UMC Utrecht, University of Utrecht, Utrecht, Netherlands. K.L.Cheng-2@umcutrecht.nl.; Division of Experimental Cardiology, Department of Cardiology, Erasmus University Medical Center, Rotterdam, Netherlands. K.L.Cheng-2@umcutrecht.nl.
Publikováno v:
Clinical epigenetics [Clin Epigenetics] 2020 Jul 14; Vol. 12 (1), pp. 106. Date of Electronic Publication: 2020 Jul 14.